Association of suicidal ideation and depression with the use of proton pump inhibitors in adults: a cross-sectional study
- PMID:36376493
- PMCID: PMC9663563
- DOI: 10.1038/s41598-022-24244-z
Association of suicidal ideation and depression with the use of proton pump inhibitors in adults: a cross-sectional study
Abstract
Proton pump inhibitors (PPIs) were found to be associated with depression. This study aimed to find the cross-sectional association between recent PPI use and suicidal ideation. Item 9 of Patient Health Questionnaire-9 (PHQ-9) of the US National Health and Nutrition Examination Survey (NHANES) between 2005 and 2018 was used to categorize whether or not the participants had suicidal ideation. The secondary outcome of this study was depression and the scores of the PHQ-9 were used as the depression diagnostic instrument. The study population included 16,881 participants who were over 20 years old. The bivariate Rao-Scott χ2 test showed a significant association between PPI use and suicidal ideation (P < 0.001) and a stronger association was observed between PPIs and depression (P < 0.001). Multiple logistic regression analysis of the education, gender, race and age-adjusted model revealed that the PPI users had a 2.34 (95% CI 1.66-3.31) greater risk of having suicidal ideation than the non-PPI users. Middle-aged participants (40-49 years) showed the greatest number of differences in suicidal ideation between PPI and non-PPI users (P < 0.001). Future research should continue to consider the psychiatric effects of taking PPIs.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
- The Association between Recent Cannabis Use and Suicidal Ideation in Adults: A Population-based Analysis of the NHANES from 2005 to 2018.Diep C, Bhat V, Wijeysundera DN, Clarke HA, Ladha KS.Diep C, et al.Can J Psychiatry. 2022 Apr;67(4):259-267. doi: 10.1177/0706743721996112. Epub 2021 Mar 1.Can J Psychiatry. 2022.PMID:33641436Free PMC article.
- Association between commensality with depression and suicidal ideation of Korean adults: the sixth and seventh Korean National Health and Nutrition Examination Survey, 2013, 2015, 2017.Son YH, Oh SS, Jang SI, Park EC, Park SH.Son YH, et al.Nutr J. 2020 Dec 2;19(1):131. doi: 10.1186/s12937-020-00650-9.Nutr J. 2020.PMID:33267833Free PMC article.
- Risk for depression and suicidal ideation among food insecure US veterans: data from the National Health and Nutrition Examination Study.Kamdar NP, Horning ML, Geraci JC, Uzdavines AW, Helmer DA, Hundt NE.Kamdar NP, et al.Soc Psychiatry Psychiatr Epidemiol. 2021 Dec;56(12):2175-2184. doi: 10.1007/s00127-021-02071-3. Epub 2021 Mar 26.Soc Psychiatry Psychiatr Epidemiol. 2021.PMID:33770225
- Association of Female Reproductive Factors with depression and suicidal ideation in postmenopausal women: Evidence from NHANES 2007-2018.Zhang S, Zhang Y, Mao J.Zhang S, et al.J Psychosom Res. 2024 Dec;187:111881. doi: 10.1016/j.jpsychores.2024.111881. Epub 2024 Aug 6.J Psychosom Res. 2024.PMID:39288470
- Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Luk CP, Parsons R, Lee YP, Hughes JD.Luk CP, et al.Ann Pharmacother. 2013 Jun;47(6):773-80. doi: 10.1345/aph.1R556. Epub 2013 Apr 30.Ann Pharmacother. 2013.PMID:23632281Review.
Cited by
- Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database.Ruggiero R, Mascolo A, Spezzaferri A, Carpentieri C, Torella D, Sportiello L, Rossi F, Paolisso G, Capuano A.Ruggiero R, et al.Pharmaceuticals (Basel). 2024 Jan 23;17(2):147. doi: 10.3390/ph17020147.Pharmaceuticals (Basel). 2024.PMID:38399362Free PMC article.
- Helicobacter pylori, esophageal precancerous lesions, and proton pump inhibitor overuse.Zhang F, Zhang H, Liu YM, Tang FS.Zhang F, et al.World J Gastroenterol. 2024 Nov 14;30(42):4591-4596. doi: 10.3748/wjg.v30.i42.4591.World J Gastroenterol. 2024.PMID:39563751Free PMC article.Review.
- Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B12 Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.Ito T, Ramos-Alvarez I, Jensen RT.Ito T, et al.Int J Mol Sci. 2024 Jul 2;25(13):7286. doi: 10.3390/ijms25137286.Int J Mol Sci. 2024.PMID:39000391Free PMC article.
- Individualized prevention of proton pump inhibitor related adverse events by risk stratification.Xia B, He Q, Smith FG, Gkoutos VG, Nirantharakumar K, Kuo ZC, Wang D, Feng Q, Cheung EC, Dai L, Huang J, Yu Y, Meng W, Qin X, Yuan J.Xia B, et al.Nat Commun. 2024 Apr 27;15(1):3591. doi: 10.1038/s41467-024-48007-8.Nat Commun. 2024.PMID:38678022Free PMC article.
References
- Abrahami D, McDonald EG, Schnitzer M, Azoulay L. Trends in prescribing patterns of proton pump inhibitors surrounding new guidelines. Ann. Epidemiol. 2021;55:24–26. - PubMed
- Savarino V, et al. Proton pump inhibitors: use and misuse in the clinical setting. Expert Rev. Clin. Pharmacol. 2018;11:1123–1134. - PubMed
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical